- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.12.25 | Ortivus AB: Ortivus informs that Ponderus Invest AB has announced approval from the Swedish Inspectorate of Strategic Products regarding the mandatory cash offer to the shareholders of Ortivus Aktiebolag | 78 | GlobeNewswire (Europe) | Ponderus Invest AB ("Ponderus") announced on 2 December 2025 a mandatory cash offer to the shareholders of Ortivus Aktiebolag ("Ortivus") to transfer all of their shares in Ortivus to Ponderus for SEK... ► Artikel lesen | |
| 18.12.25 | Ortivus AB: The independent bid committee of Ortivus unanimously recommends that shareholders do not accept the mandatory cash offer submitted by Ponderus Invest AB | 175 | GlobeNewswire (Europe) | The independent bid committee of Ortivus AB (publ) ("Ortivus" or the "Company") unanimously recommends that shareholders of Ortivus do not accept the mandatory cash offer submitted by Ponderus Invest... ► Artikel lesen | |
| 17.12.25 | Ortivus AB: Ortivus welcomes Minni Raij as new CFO | 135 | GlobeNewswire (Europe) | Ortivus is pleased to announce the appointment of Minni Raij as the new Chief Financial Officer (CFO) at Ortivus. Minni brings more than two decades of experience in finance and management. Minni will... ► Artikel lesen | |
| 02.12.25 | Ortivus AB receives observation status | 79 | GlobeNewswire | Today, December 2, 2025, Ponderus Invest AB disclosed a mandatory public offer to the other shareholders in Ortivus AB.
The rules of Nasdaq First North Growth Market state that an issuer may... ► Artikel lesen | |
| 02.12.25 | Ortivus AB: Ortivus announces mandatory public offer from Ponderus Invest AB | 90 | GlobeNewswire (Europe) | On 14 November 2025, Ponderus Invest AB announced its intention to return no later than 3 December 2025 with information regarding a potential mandatory public offer to the shareholders of Ortivus AB... ► Artikel lesen | |
| 28.11.25 | Ortivus AB: Interim Report for Ortivus AB (publ) for the period July - September 2025 | 226 | GlobeNewswire (Europe) | "The increased interest we are witnessing in the market and from existing customers, together with the high pace of our product development, gives us a positive outlook for the future."
July-September... ► Artikel lesen | |
| ORTIVUS Aktie jetzt für 0€ handeln | |||||
| 14.11.25 | Ortivus AB: Ortivus Informs About A Possible Mandatory Bid From Ponderus Invest | 112 | GlobeNewswire (Europe) | Ortivus Aktiebolag ("Ortivus" or the "Company") resolved at an extraordinary general meeting on September 19, 2025 to carry out a fully guaranteed rights issue of B shares corresponding to an issue... ► Artikel lesen | |
| 15.10.25 | Ortivus AB: Ortivus announces that CFO Johan Wewel has decided to leave his position | 106 | GlobeNewswire (Europe) | Ortivus announces today that the company's CFO, Johan Wewel, has decided to leave his position to take up a role outside the Group. Johan Wewel will remain in his current position until 7 January 2026... ► Artikel lesen | |
| 30.09.25 | Ortivus AB: Ortivus publishes information document regarding Rights Issue of shares | 97 | GlobeNewswire (Europe) | THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 19.09.25 | Ortivus AB: Press release from the Extraordinary General Meeting of Ortivus AB regarding Rights Issue | 197 | GlobeNewswire (Europe) | At the Extraordinary General Meeting of Ortivus AB (publ), held in Danderyd on 19 September 2025, the following resolutions were adopted.
For more detailed information, please refer to the full notice... ► Artikel lesen | |
| 09.09.25 | Ortivus AB: Ortivus announces intended allocation of proceeds from the proposed rights issue following agreement with the main shareholder on a new credit facility | 159 | GlobeNewswire (Europe) | Ortivus announced in a press release on 26 August 2025 that the Board of Directors had resolved to propose to an upcoming Extraordinary General Meeting the implementation of a fully guaranteed rights... ► Artikel lesen | |
| 26.05.25 | Ortivus AB: Ortivus receives two-year contract extension from Northern Ireland Ambulance Service (NIAS) | 349 | GlobeNewswire (Europe) | Ortivus AB announces that the Northern Ireland Ambulance Service (NIAS) has formally exercised its contractual right to extend its current agreement with Ortivus by an additional two (2) years. The... ► Artikel lesen | |
| 08.05.25 | Ortivus AB: Interim Report for Ortivus AB (publ) for the period January - March 2025 | 163 | GlobeNewswire (Europe) | "Our ambition is not only to deliver technology, but to be a strategic partner in the transformation of healthcare."
January - March 2025Net sales decreased by 18% and amounted to SEK 18.1 million (22.1).The... ► Artikel lesen | |
| 14.02.25 | Ortivus AB: Ortivus: Year-end report January-December 2024 | 182 | GlobeNewswire (Europe) | During the year, we have carried out extensive organisational changes and strengthened our team to support our growth journey. Additionally, we have implemented a new business system to improve financial... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,530 | +0,48 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,010 | -0,43 % | EILMELDUNG: Fresenius Medical Care-Aktie bricht ein - Panik greift um sich! | ||
| FRESENIUS | 49,750 | +1,59 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| LUMEXA IMAGING | 17,730 | +2,37 % | Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO | ||
| ALIGNMENT HEALTHCARE | 20,950 | 0,00 % | Where Alignment Healthcare Stands With Analysts | ||
| BRIGHTSPRING HEALTH SERVICES | 39,080 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| BETA BIONICS | 31,990 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | ||
| PROCEPT BIOROBOTICS | 34,480 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HEARTFLOW | 33,470 | 0,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,680 | -2,25 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| PROGYNY | 27,440 | 0,00 % | Progyny-Aktie: Truist Securities stuft auf 'Kaufen' hoch und verweist auf verbesserte Aussichten | ||
| ECKERT & ZIEGLER | 15,410 | -2,41 % | Eckert & Ziegler - Kurzbericht zur Aktienentwicklung | ||
| MIMEDX | 6,310 | -2,02 % | MiMedx Group, Inc: MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit-Wound Gel | MARIETTA, Ga., Dec. 22, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") today announced it has entered into an exclusive agreement with Regen Lab USA LLC to... ► Artikel lesen | |
| NEUROPACE | 16,960 | +0,89 % | BDMD: Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion | NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive... ► Artikel lesen | |
| BILLIONTOONE | 87,59 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen |
ORTIVUS AB gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ORTIVUS AB finden Sie auf Wallstreet Online.